Human growth hormone: a case study in treatment priorities.
D002648:Child; D003362:Cost-Benefit Analysis; D003657:Decision Making; D006233:Persons with Disabilities; D004467:Economics; D005260:Female; D005818:Genetic Engineering; D024861:Genetic Enhancement; D006130:Growth Disorders; D006262:Health; D015276:Health Care Rationing; D006728:Hormones; D006806:Human Rights; D006801:Humans; D008571:Men; D008913:Minority Groups; D005791:Patient Care; D018579:Patient Selection; D010820:Physicians; D011287:Prejudice; D011788:Quality of Life; D012015:Reference Standards; D016079:Refusal to Treat; D040841:Resource Allocation; D012306:Risk; D018570:Risk Assessment; D012935:Social Justice; D012959:Socioeconomic Factors; D013315:Stress, Psychological; D014481:United States; D014930:Women
Health Care and Public Health; Professional Patient Relationship